Lido Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Buy
27,477
+15,180
+123% +$2.16M 0.01% 584
2025
Q4
$2.4M Buy
12,297
+57
+0.5% +$9.54K 0.01% 669
2025
Q3
$2.4M Sell
12,240
-4,550
-27% -$748K 0.01% 634
2025
Q2
$1.52M Buy
16,790
+879
+6% +$69.4K 0.01% 681
2025
Q1
$949K Buy
15,911
+1,899
+14% +$176K ﹤0.01% 803
2024
Q4
$1.86M Buy
14,012
+5,986
+75% +$562K 0.01% 537
2024
Q3
$420K Buy
+8,026
New +$377K ﹤0.01% 1011

Other funds holding ALAB

Lido Advisors's ALAB Position: Q1 2026 in Review

Lido Advisors increased its Astera Labs (ALAB) stake by 123% in Q1 2026, buying an estimated $2.16M and bringing the position to 27,477 shares worth $3.01M. The position accounts for 0.01% of the portfolio, ranked #584.

Lido Advisors first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Lido Advisors held 27,477 shares of Astera Labs worth $3.01M as of Q1 2026.
  • Lido Advisors bought 15,180 Astera Labs shares in Q1 2026, an estimated $2.16M.
  • Astera Labs made up 0.01% of Lido Advisors's portfolio in Q1 2026, its #584 holding.
  • Lido Advisors first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Lido Advisors's 13F filing for Q1 2026, filed 13 May 2026.